About
TECLens is a clinical-stage ophthalmic medical device company, pioneering non-invasive personalized corneal cross-linking technology (qCXL™) for vision correction. Our innovative CXLens® system uses patterned ultraviolet (UV) light to gently reshape the cornea with continuous biomechanical control. qCXL is designed to be a comfortable, safe, and effective alternative to traditional refractive surgeries. TECLens' breakthrough technology aims to set a new standard in precision, accessibility, and patient experience—redefining vision correction with innovation that improves quality of life. Caution – Investigational device. Limited by Federal (or United States) law to investigational use.
Technologies
Keywords
Company Information
-
Employees 12
-
Founded 2013
-
Annual Revenue $2400000
-
Total Funding $19935282
Location
9 Shore Dr, Brattleboro, Vermont, United States, 05301